| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ionis Pharmaceuticals, Inc. (IONS) has 21 insiders with recent SEC Form 4 filings, including 0 buys and 16 sells. IONS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 260.3K | $19.78M | - | |
| Dir | 164.0K | $12.46M | -8,000 | |
| VP | 100.3K | $7.62M | - | |
| VP | 83.3K | $6.33M | -60,846 | |
| CFO | 82.7K | $6.28M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 19, 2019 | Wender Joseph H | Director | Sell | 10,000 | $79.63 | $796,258.00 | -14.5% | |
| Mar 18, 2019 | O'Neil Patrick R.57 | SVP Legal &General Counsel | Sale+OE | 28,800 | $78.79 | $2,269,186.56 | -59.4% | |
| Mar 12, 2019 | Parshall B Lynne74 | Director | Sale+OE | 8,334 | $75.00 | $625,050.00 | -13.7% | |
| Feb 27, 2019 | Parshall B Lynne74 | Director | Sale+OE | 8,333 | $70.00 | $583,310.00 | -13.7% | |
| Feb 27, 2019 | O'Neil Patrick R.57 | SVP Legal &General Counsel | Sale+OE | 26,800 | $68.01 | $1,822,579.52 | -31.2% | |
| Feb 26, 2019 | Crooke Stanley T | Chairman And CEO | Sale+OE | 77,000 | $60.77 | $4,679,498.70 | -35.6% | |
| Feb 13, 2019 | Geary Richard S65 | SVP, Development | Sell | 999 | $60.00 | $59,940.00 | -4.5% | |
| Feb 13, 2019 | Crooke Stanley T | Chairman And CEO | Sale+OE | 46,904 | $60.09 | $2,818,268.00 | -36.8% | |
| Feb 12, 2019 | O'Neil Patrick R.57 | SVP Legal &General Counsel | Sale+OE | 275 | $59.50 | $16,362.50 | -1.4% | |
| Feb 5, 2019 | O'Neil Patrick R.57 | SVP Legal &General Counsel | Sale+OE | 19,600 | $59.25 | $1,161,360.00 | -33.3% |